Clinical Trials Directory

Trials / Completed

CompletedNCT05911854

Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema

Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema: Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study was conducted: * To investigate the effect of MLS Laser in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment. * To investigate the effect of CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment. * To compare the effect of MLS Laser versus CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.

Conditions

Interventions

TypeNameDescription
DEVICEMulti-waved Locked System LaserThe M6 therapy laser is a robotized multi-target device designed to treat patients suffering pathologies affecting a wide area, and to perform automatic applications.
DEVICECold Compression therapyThe BioCryo Cold Compression System is a cold therapy pneumatic compression device that safely administers sequential, gradient pneumatic compression and CryoTherapy combined.
OTHERcomplete decongestive therapyComplete decongestive therapy consists of: * Meticulous skin care with the use of emollients * Using short stretch bandages or continuous wearing of a pressure garment * Manual lymphatic drainage therapy * Remedial exercises (e.g., aerobic exercise, strength training, and stretching exercises)

Timeline

Start date
2023-01-21
Primary completion
2023-05-06
Completion
2023-06-05
First posted
2023-06-22
Last updated
2023-06-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05911854. Inclusion in this directory is not an endorsement.